SAS and Pappas Capital partner to propel AgTech startups with analytics

SAS and Pappas Capital partner to propel AgTech startups with analytics

CARY, N.C., Oct. 20, 2021 -- Two North Carolina companies, analytics leader SAS and venture investment firm Pappas Capital, are joining forces to help advance the state as a global leader in agricultural technology. The state's AgTech sector is ripe for continued growth and innovation, and technologies such as artificial intelligence, machine learning and analytics are driving innovation in digital agriculture. The collaboration between SAS and Pappas will allow select NC agriculture and food startups to gain guidance and executive leadership from Pappas and access to industry-leading analytics software, data science expertise and cloud services from SAS.

Pappas Capital Strengthens Specialized Fund Management Business With Appointment Of Karen LeVert As Venture Partner

RESEARCH TRIANGLE PARK, NC, Feb. 3, 2020 -- Pappas Capital, a leading investor in early-stage life sciences companies, has appointed Karen LeVert as Venture Partner to help lead the expansion of the firm's Specialized Fund Management business, with a focus on identifying attractive investment opportunities in agricultural and other related technologies. Ms. LeVert has a proven track record of progressing early stage technologies from university research labs to commercialization, and most recently co-founded two independent innovation labs, Southeast TechInventures, Inc. (STI) and Ag TechInventures, LLC (AgTI).

Alex Arfaei Joins Pappas Capital As Partner

RESEARCH TRIANGLE PARK, N.C., Sept. 11, 2019 -- Pappas Capital, a leading investor in early-stage life sciences companies, announced today that Alex Arfaei has joined the firm as a Partner of Pappas Ventures. In his role, Mr. Arfaei will be responsible for helping to identify and evaluate investment opportunities for the firm's venture capital business. Previously, Mr. Arfaei served as a Managing Director with BMO Capital Markets, where he was a senior equity research analyst covering major pharmaceutical and biotechnology companies.

Pappas Capital Expands Leadership Team With Appointments Of Kyle Rasbach To Managing Partner And Matthew Boyer To Chief Financial Officer

RESEARCH TRIANGLE PARK, NC, July 16, 2019 -- Pappas Capital, a leading investor in early-stage life sciences companies, today announced the promotion of Kyle Rasbach, PhD, PharmD to a Managing Partner of Pappas Ventures, the firm's venture capital business. In his new role, Dr. Rasbach will help to oversee Pappas Ventures and lead fundraising and investment efforts for its future venture funds. Pappas Capital also announced that Matthew Boyer has been named Chief Financial Officer, succeeding Ford Worthy who will continue with the firm as a Partner and Senior Advisor.

New Pappas Capital Fund Makes First Investment

Research Triangle Park, NC, May 24, 2017 – Pappas Capital, a life science venture capital firm, announced today that its new fund, Pappas Ventures V, recently invested in OrphoMed, a clinical stage company that is developing best-in-class therapies for treatment of inadequately-controlled gastrointestinal disorders. The investment in OrphoMed is the first investment by the new Pappas Ventures fund.